Who are Ros weight loss offerings for
In studies of people with type 2 diabetes inadequately controlled on basal insulin or GLP-1 RA, switching to a fixed-ratio combination of basal insulin and GLP-1 RA demonstrated significant improvements in blood glucose levels and achievement of glycaemic goals with fewer hypoglycaemic events than with basal insulin alone [216,217,218,219,220]
Blue Cross Blue Shield of Massachusetts and Point32Health are discontinuing coverage of GLP-1 medications for weight loss, and CVS Caremark has restricted its formulary to Wegovy, removing Zepbound
Your GLP-1 day, made simple
As with any powerful therapy, there are questions we still need to answer: how these drugs behave over decades, how to protect lean mass at scale, how to dose safely in metabolically healthy individuals, how to separate genuine medical use from cosmetic hype, and how to ensure patients are not starved of protein or muscle
The cells in the caudal nucleus of the solitary tract receive direct vagal sensory afferent input, and their axons branch widely to reach a large number of subcortical targets
/assets/images/provider/photos/2775905.jpeg)
